ARE MOLECULAR-WEIGHT AND ANTI-XA ACTIVITY SUFFICIENT TO PREDICT THE ANTITHROMBOTIC POWER OF HEPARIN FRACTIONS

被引:13
作者
DOUTREMEPUICH, C [1 ]
BOUSQUET, F [1 ]
TOULEMONDE, F [1 ]
机构
[1] INST CHOAY,F-75016 PARIS,FRANCE
关键词
D O I
10.1016/0049-3848(86)90172-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:709 / 712
页数:4
相关论文
共 4 条
[1]   LACK OF CORRELATION BETWEEN INVITRO AND INVIVO ANTITHROMBOTIC ACTIVITY OF HEPARIN FRACTIONS AND RELATED-COMPOUNDS - HEPARAN-SULFATE AS AN ANTITHROMBOTIC AGENT INVIVO [J].
BIANCHINI, P ;
OSIMA, B ;
PARMA, B ;
NADER, HB ;
DIETRICH, CP .
THROMBOSIS RESEARCH, 1985, 40 (05) :597-607
[2]  
DOUTREMEPUICH C, 1983, HAEMOSTASIS, V13, P109
[3]   FAILURE OF ASPIRIN AT DIFFERENT DOSES TO MODIFY EXPERIMENTAL THROMBOSIS IN RATS [J].
REYERS, I ;
MUSSONI, L ;
DONATI, MB ;
DEGAETANO, G .
THROMBOSIS RESEARCH, 1980, 18 (05) :669-674
[4]   HEPARIN AND A LOW-MOLECULAR WEIGHT FRACTION ENHANCES THROMBOLYSIS AND BY THIS PATHWAY EXERCISES A PROTECTIVE EFFECT AGAINST THROMBOSIS [J].
VAIREL, EG ;
BOUTYBOYE, H ;
TOULEMONDE, F ;
DOUTREMEPUICH, C ;
MARSH, NA ;
GAFFNEY, PJ .
THROMBOSIS RESEARCH, 1983, 30 (03) :219-224